What's new? Log in Free sign up

Filing search / Context Therapeutics Inc. / "Retirement"

Search information

Context Therapeutics Inc.

Companies

"Retirement"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

33 results

Newest first Best match first

CNTX Context Therapeutics Inc.

Shelf registration

shall be applicable to any sinking fund for the retirement of the Securities of a Series if so provided by the terms of such Securities pursuant

6 Nov 24

4:42pm

CNTX Context Therapeutics Inc.

Quarterly report

and former trustees and administrators of each retirement and other benefit plan applicable to the employees and former employees of the Company, both … Act of 1964, (iii) The Civil Rights Act of 1991, (iv) The Equal Pay Act, (v) The Employee Retirement Income Security Act of 1974, (vi) The Age

7 Aug 24

4:07pm

CNTX Context Therapeutics Inc.

Definitive proxy

, including employment agreements, severance arrangements, transition or consulting agreements, retirement agreements and change-in-control agreements … . West served in multiple leadership roles of increasing responsibility for E. I. du Pont de Nemours and Company from 1981 until her retirement

26 Apr 24

4:10pm

CNTX Context Therapeutics Inc.

effort to recover the Erroneously Awarded Compensation; or the recovery would likely cause a U.S. tax-qualified retirement plan to fail to meet

21 Mar 24

7:36am

CNTX Context Therapeutics Inc.

Definitive proxy

as the Compensation Committee determines, including employment agreements, severance arrangements, transition or consulting agreements, retirement … responsibility for E. I. du Pont de Nemours and Company from 1981 until her retirement in November 2019. Ms. West most recently served as Vice President

6 Apr 23

4:02pm

x5taopuiug24spdkec

Shelf registration

2ep n75mvvm2avq3

Prospectus supplement

qcd vpyololt3eqak

Prospectus update (post-effective amendment)

Definitive proxy

Context Therapeutics® Strengthens Research & Development Team

6dus6lfphwkxtj2l8

Context Therapeutics® Strengthens Research & Development Team

jqyl1fp9nbd9s4iuqd

Prospectus supplement with pricing info

xeu4ut473wiqf1 4nnfj

IPO registration

10 Dec 21

4:46pm

Context Therapeutics® Strengthens Leadership Team with Appointments of Chief Financial Officer and Chief Legal Officer

glxjocrpuuhcpuyp7

Departure of Directors or Certain Officers

tsi7bf73qldrrok0rhp

Prospectus supplement with pricing info

IPO registration (amended)

18 Oct 21

12:00am

IPO registration (amended)

29 Sep 21

8:24am

IPO registration (amended)

24 Sep 21

4:15pm

Prev
1
2
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.